Old MS Drug May Improve Cognitive Function

Old MS Drug May Improve Cognitive Function

Publication date: Aug 06, 2019

Old MS Drug May Improve Cognitive Function Old MS Drug May Improve Cognitive Function Dalfampridine, approved almost a decade ago for improving walking for patients with multiple sclerosis, may also improve information-processing speed, a measure of cognitive function, new research suggests. Medscape Medical News Purpose of review To review recent studies which assess comorbidity, that is, prevalence of co-occurrence, relationships and treatment implications between anxiety disorders and various medical illnesses. Recent findings The prevalence rates of anxiety disorders in patients with medical illnesses are high, with percentage up to 29% in patients with epilepsy, 48. 9% in patients with multiple sclerosis, 30. 1% in patients with Parkinson’s disease, 30% in patients with cardiovascular disease, 47. 0% in patients with diabetes mellitus, and so on. Source: – Category: Psychiatry Tags: PSYCHIATRY, MEDICINE AND THE BEHAVIOURAL SCIENCES: Edited by Mohan Isaac and Igor Filipcic Source Type: research PsychiatryPSYCHIATRY, MEDICINE AND THE BEHAVIOURAL SCIENCES: Edited by Mohan Isaac and Igor Filipcicresearch Profound and debilitating fatigue is the most common complaint reported among individuals with autoimmune disease, such as systemic lupus erythematosus, multiple sclerosis, type 1 diabetes, celiac disease, chronic fatigue syndrome, and rheumatoid arthritis. Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech Republic from 2013-2016: data from the national registry ReMuS Conclusion: Data from the ReMuS registry highlights improvements made in the management of MS in the Czech Republic. Role of diet and gut microbiota in multiple sclerosis: New findings on the role of high -salt intake in induction of neuroinflammation This article is a snapshot of the recent findings about the putative role of high-salt and high-fat intake in the pathogenesis of MS. AbstractMultiple etiological factors are involved in the pathogenesis of multiple sclerosis (MS). AbstractBackgroundHypertension is a prevalent and impactful comorbid condition among patients with multiple sclerosis (MS).

Concepts Keywords
Accounting Organ systems
Anxiety Disorders Autoimmunity
Aphasia Multiple sclerosis
Autoimmune Disease Neuromyelitis optica
Autoimmune Diseases Chronic fatigue syndrome
Basal Ganglia CCR5
Blood Pressure Neurology
BMI Autoimmune diseases
Body Fat Immunology
Body Mass Medicine
BP Medical specialties
Brainstem Cure complex disorders
Brighton Cardiovascular disease
Cardiovascular Disease Why multiple sclerosis
CCR5 MS
Celiac Disease Broca s aphasia
Chemokine Acute inflammation
Chemokines Epilepsy
Chronic Fatigue Syndrome Prevalent anxiety disorders
Cognitive Function Rheumatoid arthritis Fatigue
Comorbid Multiple sclerosis
Comorbidity HIV
Cortical Diabetes mellitus
CXCR4 Chronic inflammation
Cytokines Fatigue
Czech Republic Parkinson s disease
Diabetes Infection CCR5 CXCR4
Diabetes Mellitus
Disability
Encephalitis
Epilepsy
Etiological Factors
Fat Mass
Fatigue
Gut Microbiota
HIV
Infection
Inflammation
Leukocyte
Malignancy
Medscape
MOG
Multiple Sclerosis
Neuromyelitis Optica
NMDAR
Parkinson
Pathogenesis
Pathology
Receptors
Rheumatoid Arthritis
Salt
Somatic
Spectrum
Synergistic
Systemic Lupus Erythematosus
Wheelchair

Semantics

Type Source Name
drug DRUGBANK Dalfampridine
disease MESH multiple sclerosis
disease DOID multiple sclerosis
disease MESH comorbidity
disease MESH anxiety disorders
disease MESH epilepsy
disease DOID epilepsy
disease MESH cardiovascular disease
disease MESH diabetes mellitus
disease DOID diabetes mellitus
disease MESH autoimmune disease
disease DOID autoimmune disease
disease MESH systemic lupus erythematosus
disease DOID systemic lupus erythematosus
pathway BSID Systemic lupus erythematosus
disease MESH type 1 diabetes
disease DOID celiac disease
disease MESH chronic fatigue syndrome
disease DOID chronic fatigue syndrome
disease MESH rheumatoid arthritis
disease DOID rheumatoid arthritis
pathway BSID Rheumatoid arthritis
disease MESH multi
disease MESH anti-NMDAR encephalitis
drug DRUGBANK Isoxaflutole
disease MESH aphasia
disease DOID aphasia
gene UNIPROT MOG
gene UNIPROT FAT1
gene UNIPROT CD36
disease MESH neuromyelitis optica spectrum disorder
gene UNIPROT CCR5
gene UNIPROT CCR2
disease MESH inflammation
disease MESH malignancy
gene UNIPROT RXFP2
gene UNIPROT HINT1
disease MESH HIV infection
disease DOID HIV infection
pathway BSID HIV Infection
gene UNIPROT CXCR4
gene UNIPROT NR4A2
gene UNIPROT ALG3
drug DRUGBANK Maraviroc

Leave a Comment

Your email address will not be published. Required fields are marked *